Expert Opinion on Therapeutic Targets logo Informa Healthcare logo

Publisher: Informa Healthcare

Volume 9, Number 4, 1 August 2005
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Review article

Novel therapeutic targets for Huntington’s disease
pp. 639-650(12)
Author: Hannan, Anthony J

The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders
pp. 651-684(34)
Author: Grigoriadis, Dimitri E

New targets for neuropathic pain therapeutics
pp. 685-698(14)
Authors: Kinloch, Ross A; Cox, Peter J

The ERK/MAPK pathway, as a target for the treatment of neuropathic pain
pp. 699-713(15)
Authors: Ma, Weiya; Quirion, Remi

Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges
pp. 715-736(22)
Authors: Hu, Erding; Lee, Dennis

Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes
pp. 737-752(16)
Author: Barton, Beverly E

The insulin-like growth factor-I receptor as a target for cancer therapy
pp. 753-768(16)
Author: Baserga, Renato

The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck
pp. 769-790(22)
Authors: Rogers, Susanne J; Box, Carol; Harrington, Kevin J; Nutting, Chris; Rhys-Evans, Peter; Eccles, Suzanne A

Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy
pp. 791-808(18)
Authors: Rodriguez-Mora, Oswaldo; LaHair, Michelle M; Howe, Christopher J; McCubrey, James A; Franklin, Richard A

Histone deacetylase inhibitors: insights into mechanisms of lethality
pp. 809-824(16)
Authors: Rosato, Roberto R; Grant, Steven

Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma
pp. 825-830(6)
Authors: Maksimenko, Andrei; Malvy, Claude

Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors
pp. 831-849(19)
Authors: Muller, Alexander J; Malachowski, William P; Prendergast, George C

Phosphoproteomics for oncology discovery and treatment
pp. 851-860(10)
Author: Stern, David F

Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases
pp. 861-873(13)
Authors: Bedu, Elodie; Wahli, Walter; Desvergne, Béatrice

Miscellaneous

Neuromedin U – a new target in obesity
pp. 875-877(3)
Author: Doggrell, Sheila A

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A